{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T11:39:15Z","timestamp":1765712355579,"version":"3.48.0"},"reference-count":30,"publisher":"BMJ","issue":"7","funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["PB-PG-0613-31073"],"award-info":[{"award-number":["PB-PG-0613-31073"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2016,5,25]]},"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Gastrointestinal dysmotility and constipation are common problems in intensive care patients. The majority of critical care patients are sedated with opioids to facilitate tolerance of endotracheal tubes and mechanical ventilation, which inhibit gastrointestinal motility and lead to adverse outcomes. Methylnaltrexone is a peripheral opioid antagonist that does not cross the blood\u2013brain barrier and can reverse the peripheral side effects of opioids without affecting the desired central properties. This trial will investigate whether methylnaltrexone can reverse opioid-induced constipation and gastrointestinal dysmotility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This is a single-centre, multisite, double-blind, randomised, placebo-controlled trial. 84 patients will be recruited from 4 intensive care units (ICUs) within Imperial College Healthcare NHS Trust. Patients will receive intravenous methylnaltrexone or placebo on a daily basis if they are receiving opioid infusion to facilitate mechanical ventilation and have not opened their bowels for 48\u2005hours. All patients will receive standard laxatives as per the clinical ICU bowel protocol prior to randomisation. The primary outcome of the trial will be time to significant rescue-free laxation following randomisation. Secondary outcomes will include tolerance of enteral feed, gastric residual volumes, incidence of pneumonia, blood stream and\n                      <jats:italic>Clostridium difficile<\/jats:italic>\n                      infection, and any reversal of central opioid effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The trial protocol, the patient\/legal representative information sheets and consent forms have been reviewed and approved by the Harrow Research Ethics Committee (REC Reference 14\/LO\/2004). An independent Trial Steering Committee and Data Monitoring Committee are in place, with patient representation. On completion, the trial results will be published in peer-reviewed journals and presented at national and international scientific meetings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>2014-004687-37; Pre-results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-011750","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T02:52:22Z","timestamp":1468464742000},"page":"e011750","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Protocol for a randomised control trial of methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients (MOTION)"],"prefix":"10.1136","volume":"6","author":[{"given":"Parind B","family":"Patel","sequence":"first","affiliation":[{"name":"Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, London, UK"},{"name":"Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J","family":"Brett","sequence":"additional","affiliation":[{"name":"Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, London, UK"},{"name":"Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"O'Callaghan","sequence":"additional","affiliation":[{"name":"Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Anjum","sequence":"additional","affiliation":[{"name":"Imperial Clinical Trials Unit, Faculty of Medicine, School of Public Health, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Cross","sequence":"additional","affiliation":[{"name":"Imperial Clinical Trials Unit, Faculty of Medicine, School of Public Health, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Warwick","sequence":"additional","affiliation":[{"name":"Warwick Clinical Trials Unit, University of Warwick, Coventry, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony C","family":"Gordon","sequence":"additional","affiliation":[{"name":"Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, London, UK"},{"name":"Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,7,13]]},"reference":[{"key":"2025121403344853000_6.7.e011750.1","doi-asserted-by":"crossref","first-page":"630.e9","DOI":"10.1016\/j.jcrc.2009.03.007","article-title":"Constipation in intensive care unit: incidence and risk factors","volume":"24","author":"Nassar","year":"2009","journal-title":"J Crit Care"},{"key":"2025121403344853000_6.7.e011750.2","first-page":"2726","article-title":"Laxation of critically ill patients with lactulose or polyethylene glycol: a two-center randomized, double-blind, placebo-controlled trial","volume":"35","author":"van der Spoel","year":"2007","journal-title":"Crit Care Med"},{"key":"2025121403344853000_6.7.e011750.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70492-0"},{"key":"2025121403344853000_6.7.e011750.4","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeg275"},{"key":"2025121403344853000_6.7.e011750.5","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1097\/CCM.0b013e3181eb9236","article-title":"Constipation in long-term ventilated patients: associated factors and impact on intensive care unit outcomes","volume":"38","author":"Gacouin","year":"2010","journal-title":"Crit Care Med"},{"key":"2025121403344853000_6.7.e011750.6","doi-asserted-by":"publisher","DOI":"10.4065\/83.10.1116"},{"key":"2025121403344853000_6.7.e011750.7","doi-asserted-by":"publisher","DOI":"10.1007\/BF01709548"},{"key":"2025121403344853000_6.7.e011750.8","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000053652.80849.9F"},{"key":"2025121403344853000_6.7.e011750.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707377"},{"key":"2025121403344853000_6.7.e011750.10","doi-asserted-by":"crossref","first-page":"9081","DOI":"10.1200\/jco.2007.25.18_suppl.9081","article-title":"Methylnaltrexone treatment of opioid-induced constipation in cancer patients","volume":"25","author":"Karver","year":"2007","journal-title":"J Clin Oncol"},{"key":"2025121403344853000_6.7.e011750.11","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e31818556d3"},{"key":"2025121403344853000_6.7.e011750.12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/IGC.0b013e3181cd1828","article-title":"Subcutaneous methylnaltrexone to restore postoperative bowel function in a long-term opiate user","volume":"20","author":"Ladanyi","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"2025121403344853000_6.7.e011750.13","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.jpedsurg.2010.10.015","article-title":"Resolution of opioid-induced postoperative ileus in a newborn infant after methylnaltrexone","volume":"46","author":"Garten","year":"2011","journal-title":"J Pediatr Surg"},{"key":"2025121403344853000_6.7.e011750.14","doi-asserted-by":"crossref","unstructured":"Moss J , Dickerson D , Nunnally M , et al . Methylnaltrexone treats opioid-induced bowel dysfunction in three critically ill patients. American College of Gastroenterology Annual Scientific Meeting. 2011:766.","DOI":"10.14309\/00000434-201110002-00987"},{"key":"2025121403344853000_6.7.e011750.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2011.11.014"},{"key":"2025121403344853000_6.7.e011750.16","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-3565(25)38224-8","article-title":"Morphine induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone","volume":"265","author":"Lysle","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"2025121403344853000_6.7.e011750.17","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0022-3565(25)13105-4","article-title":"Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status","volume":"277","author":"Lysle","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"2025121403344853000_6.7.e011750.18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701138"},{"key":"2025121403344853000_6.7.e011750.19","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90476-7"},{"key":"2025121403344853000_6.7.e011750.20","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(93)90122-J"},{"key":"2025121403344853000_6.7.e011750.21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0034-7094(12)70169-1","article-title":"Opioids and the immune system: clinical relevance","volume":"62","author":"Garcia","year":"2012","journal-title":"Rev Bras Anestesiol"},{"key":"2025121403344853000_6.7.e011750.22","doi-asserted-by":"publisher","DOI":"10.1097\/01.mjt.0000132250.95650.85"},{"key":"2025121403344853000_6.7.e011750.23","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000194725.48928.3A"},{"key":"2025121403344853000_6.7.e011750.24","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3182331870"},{"key":"2025121403344853000_6.7.e011750.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2010.07.002"},{"key":"2025121403344853000_6.7.e011750.26","unstructured":"U.S. Food and Drug Administration. http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/ucm221639.htm"},{"key":"2025121403344853000_6.7.e011750.27","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e3182092bde"},{"key":"2025121403344853000_6.7.e011750.28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.3.367"},{"key":"2025121403344853000_6.7.e011750.29","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004273491"},{"key":"2025121403344853000_6.7.e011750.30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4103\/1817-1737.69113","article-title":"Prophylactic use of laxative for constipation in critically ill patients","volume":"5","author":"Masri","year":"2010","journal-title":"Ann Thorac Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-011750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T11:34:54Z","timestamp":1765712094000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-011750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,13]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1136\/bmjopen-2016-011750"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-011750","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}